Urinary tract infections affect more than 130 million people worldwide each year. Almost 50% of women will have at least one urinary tract infection during their lifetime, usually cystitis. Half of them will have recurrent cystitis. Antibiotics are the first-line treatment for cystitis, but their effectiveness is decreasing due to the rapid spread of multi-resistant uro-pathogenic bacteria. The objective of this study is to identify blood biomarkers associated with a high risk of recurrent cystitis. Immune system cells, and more specifically innate immunity cells, play a key role in controlling urinary tract infections. In addition, clinical studies have shown that there is a high inter-individual variability in the ability of innate immune cells to respond to different stimuli. We therefore hypothesized that there was an association between the risk of recurrent cystitis and a deficiency of certain immune cell types in producing certain pro-inflammatory cytokines, including TNF-α, in response to one or more bacterial stimuli, particularly flagellin.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
109
23 mL of blood will be collected during the inclusion visit
Fecal sample self-collected after the inclusion visit
10 mL of urine will be collected during the inclusion visit
Sample of vaginal microbiota collected during the inclusion visit
Hôpital de l'Archet 1 - CHU de Nice - Service d'Infectiologie
Nice, France
TNF-α measurement in blood cell culture media using Luminex® technology.
The concentrations of TNF-α will be expressed in ng/ml by calibration with a standard range.
Time frame: At 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.